Li Chao, Zhou Xiaoyan, Chen Jianhui, Lu Yilu, Sun Qianqian, Tao Dachang, Hu Wei, Zheng Xulei, Bian Shasha, Liu Yunqiang, Ma Yongxin
Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Oncotarget. 2015 Sep 29;6(29):27794-804. doi: 10.18632/oncotarget.4533.
Human PIWIL1, alias HIWI, is a member of Piwi protein family and expressed in various tumors. However, the underlying mechanism of PIWIL1 in tumorigenesis remains largely unknown. Stathmin1 is a cytosolic phosphoprotein which has a critical role in regulating microtubule dynamics and is overexpressed in many cancers. Here we report that PIWIL1 can directly bind to Stathmin1. Meanwhile, PIWIL1 can up-regulate the expression of Stathmin1 through inhibiting ubiquitin-mediated degradation induced by an E3 ubiquitin ligase RLIM. Furthermore, PIWIL1 can also reduce phosphorylation level of Stathmin1 at Ser-16 through inhibiting the interaction between CaMKII and Stathmin1. Our results showed that PIWIL1 suppresses microtubule polymerization, and promotes cell proliferation and migration via Stathmin1 for the first time. Our study reveals a novel mechanism for PIWIL1 in tumorigenesis.
人PIWIL1,别名HIWI,是Piwi蛋白家族的成员,在多种肿瘤中表达。然而,PIWIL1在肿瘤发生中的潜在机制仍 largely未知。Stathmin1是一种胞质磷蛋白,在调节微管动力学中起关键作用,并且在许多癌症中过表达。在这里我们报告PIWIL1可以直接结合Stathmin1。同时,PIWIL1可以通过抑制E3泛素连接酶RLIM诱导的泛素介导的降解来上调Stathmin1的表达。此外,PIWIL1还可以通过抑制CaMKII与Stathmin1之间的相互作用来降低Stathmin1在Ser-16处的磷酸化水平。我们的结果首次表明PIWIL1通过Stathmin1抑制微管聚合,并促进细胞增殖和迁移。我们的研究揭示了PIWIL1在肿瘤发生中的一种新机制。